4-Bromo-1,3-bis(trifluoromethyl)benzene

We are 4-Bromo-1,3-bis(trifluoromethyl)benzene CAS:327-75-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-Bromo-1,3-bis(trifluoromethyl)benzene
CAS.NO:327-75-3
Synonyms:4-Bromo-1,3-bis(trifluoromethyl)benzene
1-Bromo-2,4-bis(trifluoromethyl)benzene
2,4-Bis(trifluoromethyl)bromobenzene
2,4-Bis(trifluoromethyl)-1-bromobenzene
 
Physical and Chemical Properties:
Density 1.7±0.1 g/cm3
Boiling Point 159.0±0.0 °C at 760 mmHg
Molecular Formula C8H3BrF6
Molecular Weight 293.004
Flash Point 69.4±0.0 °C
Vapour Pressure 3.3±0.2 mmHg at 25°C
Index of Refraction 1.422
 
Specification:
Appearance:Colorless to light yellow transparent liquid
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.

4-Bromo-1,3-bis(trifluoromethyl)benzene


Related News: Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.Bis (4-bifenilil) amina CAS:102113-98-4 On the other hand, the company has many new products in recent years, including Duqiao Base, Yancheng United Chemical and Dezhou United Chemical. These new products are mostly customized products with strong profitability, which has improved the gross profit margin of the industrial business.5-Methyl-3-nitropyridin-2-amine On the other hand, the company has many new products in recent years, including Duqiao Base, Yancheng United Chemical and Dezhou United Chemical. These new products are mostly customized products with strong profitability, which has improved the gross profit margin of the industrial business.4-clorobenzaldehído CAS:104-88-1 It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion.It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion.

Related Products
Product Name
5-nitro-2,3-dihydro-1-benzofuran View Details
7-Chloro-1,2,3,4-Tetrahydro-Benzo[B]Azepin-5-One View Details
3-(Benzoylthio)-2-methylpropanoic acid View Details
2,8-dibromodibenzofuran manufacturer 6-Hydroxy-2(1H)-3,4-dihydroquinolinone manufacturer 2-Methoxy-6-methylpyridine manufacturer 3-(Trifluoromethyl)benzonitrile manufacturer 4-(1,2-Benzothiazol-3-yl)-1-[(3aR,7aR)-octahydro-2H-isoindol-2-yl ]piperazin-1-ium-1-sulfonate manufacturer